Pharmaco-invasive approach for acute myocardial infarction

Area of Science:

• Cardiology
• Emergency Medicine
• Public Health

Background:

• Acute ST-segment elevation myocardial infarction (STEMI) requires timely reperfusion.
• Percutaneous coronary intervention (PCI) and fibrinolysis are established reperfusion strategies.
• The pharmacoinvasive approach combines pharmacological and mechanical reperfusion.

Purpose of the Study:

• To review landmark trials supporting the pharmacoinvasive approach for STEMI.
• To propose a pragmatic Indian model for STEMI management.
• To enhance patient stratification and standardize care.

Main Methods:

• Review of landmark clinical trials on reperfusion therapies for STEMI.
• Development of the TRANSFER-AMI-Pragmatic Indian model.
• Consideration of patient factors like hemodynamic and financial status for categorization.

Main Results:

• The pharmacoinvasive approach, using tenecteplase and PCI, consolidates reperfusion and prevents reocclusion.
• The proposed model facilitates patient organization based on clinical and economic factors.
• Standardized care models can improve inter-sectoral collaboration (prehospital, hospitals, government).

Conclusions:

• The pharmacoinvasive strategy is a valuable complement to primary PCI for STEMI.
• A pragmatic, categorized model can optimize STEMI treatment pathways.
• Regional systems of care are crucial for timely and adequate reperfusion therapy in STEMI patients.